Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Compare the efficacy of heme arginate, singly or in combination with tin
mesoporphyrin, in lowering porphyrin precursors in patients with asymptomatic acute
intermittent porphyria.
II. Evaluate and compare the safety and tolerability of these treatment regimens in this
patient population.